Renske Goedemans

M2 Macrophages Induced by Prostaglandin E2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4+ Th1 Cells

Moniek Heusinkveld, Peggy J. de Vos van Steenwijk, Renske Goedemans et al. · The Journal of Immunology · 2011 · 362 citations · Full text

Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment

Eveline M. Dijkgraaf, Moniek Heusinkveld, Bart Tummers et al. · Cancer Research · 2013 · 343 citations · Full text

Cancer-supporting M2 Macrophages, Immunology, Biological Microenvironments +20

A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer

E. M. Dijkgraaf, Saskia J. Santegoets, A.K.L. Reyners et al. · Annals of Oncology · 2015 · 189 citations

Medicine, Immunology, Pathology +6

Intratumoral HPV16-Specific T Cells Constitute a Type I–Oriented Tumor Microenvironment to Improve Survival in HPV16-Driven Oropharyngeal Cancer

Marij J.P. Welters, Wenbo Ma, Saskia J. Santegoets et al. · Clinical Cancer Research · 2017 · 162 citations · Full text

Tumor‐infiltrating CD14‐positive myeloid cells and CD8‐positive T‐cells prolong survival in patients with cervical carcinoma

Peggy J. de Vos van Steenwijk, Tamara H. Ramwadhdoebé, Renske Goedemans et al. · International Journal of Cancer · 2013 · 121 citations · Full text

Immunology, Immunologic Mechanism, Immunotherapy +18